Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • Study Involving CHOP Researchers Could Lead to More Precise Treatment for Acute Myeloid Leukemia, Children's Hospital of Philadelphia

Study Involving CHOP Researchers Could Lead to More Precise Treatment for Acute Myeloid Leukemia, Children's Hospital of Philadelphia

8 Jun 2020 11:05 AM | Anonymous

A new study involving researchers from Children’s Hospital of Philadelphia has identified immune biomarkers in patients with acute myeloid leukemia (AML) that can help predict which patients will be resistant to chemotherapy and which might benefit from a new immunotherapy.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software